Skip to main content

Table 1 Clinical characteristics of patients with cervical squamous cell carcinoma

From: Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma

Clinical characteristics NACT group (n = 64) Conventional group (n = 39) t/χ2 P Chemotherapy-insensitive group (n = 33) Chemotherapy-sensitive group (n = 31) t/χ2 P
Age 47.25 ± 8.45 47.97 ± 8.23 − 0.422 0.674 47.30 ± 6.83 47.19 ± 10.00 0.051 0.960
Pathological grade    0.840 0.657    6.142 0.057
G1 16 (25.0) 13 (33.3)    7 (21.2) 9 (29.0)   
G2 41 (64.1) 22 (56.4)    25 (75.8) 16 (51.6)   
G3 7 (10.9) 4 (10.3)    1 (3.0) 6 (19.4)   
Lymph nodes    1.114 0.391    1.502 0.220
Positive 26 (40.6) 20 (51.3)    11 (33.3) 15 (48.4)   
Negative 38 (59.4) 19 (48.7)    22 (66.7) 16 (51.6)   
The number of positive lymph nodes 1.0 (1.0, 4.0) 1.0 (1.0, 3.0) −0.012 0.991 1.0 (1.0, 3.0) 1.0 (1.0, 4.0) −0.339 0.734
FIGO    3.232 0.072    0.119 0.730
Ib2 22 (34.4) 7 (17.9)    12 (36.4) 10 (32.3)   
IIA2 42 (65.6) 32 (82.1)    21 (63.6) 21 (67.7)   
Lesion size 5.10 ± 1.40 5.12 ± 0.74 −0.061 0.944 4.86 ± 1.47 5.36 ± 1.31 −1.419 0.161